No black box warning on record for Enalaprilat

As of the latest FDA labeling reviewed, Enalaprilat (ENALAPRILAT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Enalaprilat medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Hypotension Excessive hypotension is rare in uncomplicated hypertensive patients but is a possible consequence of the use of enalaprilat especially in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis. Patients at risk for excessive hypotension, sometimes associated with oliguria and/or progressive azotemia, and rarely with acute

No black box warning on record for Enalaprilat

Other warnings & precautions

WARNINGS Hypotension Excessive hypotension is rare in uncomplicated hypertensive patients but is a possible consequence of the use of enalaprilat especially in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis. Patients at risk for excessive hypotension, sometimes associated with oliguria and/or progressive azotemia, and rarely with acute

Enalaprilat Black Box Warning

No black box warning on record for Enalaprilat

Other warnings & precautions

Enalaprilat Black Box Warning

No black box warning on record for Enalaprilat

Other warnings & precautions